Introduction {#sec1}
============

Liver cancer is a leading cause of cancer-related mortality,[@bib1] and hepatocellular carcinoma (HCC) accounts for over 80% of all cases.[@bib2] Particularly, approximately half of HCC cases occur in China.[@bib3] Cisplatin-based chemotherapy has been widely used for HCC treatment.[@bib4] However, many HCC patients displayed a negative response after chemotherapy due to the acquisition of drug resistance.[@bib5] Besides, the postoperative living quality of HCC patients is not satisfying, despite the recent advancements in HCC treatment, including surgical resection, transplantation, radiofrequency, and chemotherapy.[@bib6]^,^[@bib7] Therefore, it is crucial to further explore the underlying mechanisms of progression and chemoresistance of HCC.

It has been recently demonstrated that the melanoma-associated antigen A (MAGEA) family is involved in cancer progression, including HCC, gastric cancer, and lung adenocarcinoma.[@bib8], [@bib9], [@bib10] As a member of the MAGEA family situated in the X chromosome, MAGEA3 is widely known to be frequently and highly expressed in numerous cancers, including melanoma, lung, and ovarian cancer.[@bib11] It was reported that MAGEA3 is closely correlated to poor clinical prognosis of non-small cell lung cancer patients, downregulation of which contributes to preventing cancer progression.[@bib12] Moreover, through prediction by four databases, miRTarBase, [microRNA.org](http://microRNA.org){#intref0010}, TargetScan, and mirDIP, it was found that MAGEA3 was highly expressed in HCC and could be targeted by microRNA-31-5p (miR-31-5p). On the other hand, miRs and long non-coding RNA (lncRNAs) have been identified to influence the properties and chemoresistance of cancer cells either directly or indirectly.[@bib13] Restoration of miR-31-5p was shown to attenuate HCC cell growth, migration, and invasion.[@bib14] Another study suggested that miR-31 downregulation weakens the chemoresistance of gallbladder cancer cells to cisplatin.[@bib15] Moreover, lncRNAs can act to titrate miRNAs and thus restrain miRNA-mRNA binding.[@bib16]^,^[@bib17] For example, lncRNA LINC00066 has been found to play an oncogenic role in HCC by negatively modulating miR-214 expression.[@bib18] LINC01234 has been previously highlighted as a prognostic biomarker predicting a low overall survival for ovarian cancer patients.[@bib19] Bioinformatics prediction by the RNA22 website (<https://cm.jefferson.edu/rna22/>) revealed that lncRNA LINC01234 could bind to miR-31-5p.

Hence, a hypothesis is proposed that LINC01234 might bind to miR-31-5p to regulate MAGEA3, which may be associated with the progression and chemoresistance of HCC. Thus, we sought to investigate the function and potential mechanism of LINC01234 in the progression and chemoresistance of HCC and determine the interaction among LINC01234, miR-31-5p, and MAGEA3 in these processes.

Results {#sec2}
=======

LINC01234/miR-31-5p/MAGEA3 Axis Is Involved in HCC {#sec2.1}
--------------------------------------------------

Initially, the gene-expressed profiles of 374 HCC and 50 normal livers in The Cancer Genome Atlas (TCGA) database were analyzed. The false discovery rate (FDR) \< 0.05 and \|log2 (fold change)\| \> 2 between both the HCC and normal tissue were set as the criteria to filter differentially expressed genes (DEGs). Expression of MAGEA3 was higher than that in the normal liver (p \< 0.0001) ([Figure 1](#fig1){ref-type="fig"}A). As displayed in [Figure 1](#fig1){ref-type="fig"}B, a negative correlation was observed, and an elevated MAGEA3 expression often indicated poor prognosis of HCC (p \< 0.0001). Next, we examined the potential miRNAs associated with MAGEA3, and miR-31-5p and miR-448 were predicated to be the possible miRNAs targeting MAGEA3 from miRTarBase (<http://mirtarbase.mbc.nctu.edu.tw/php/search.php>), [microRNA.org](http://microRNA.org){#intref0025} (<http://www.microrna.org/microrna/microrna/getMirnaForm.do>), TargetScan (<http://www.targetscan.org/vert_71/>), and mirDIP (<http://ophid.utoronto.ca/mirDIP/>) ([Figure 1](#fig1){ref-type="fig"}C). Additionally, the RNA22 website (<https://cm.jefferson.edu/rna22/>) further predicted that LINC01234 could potentially bind to miR-31-5p. Expression of LINC01234 was higher in HCC compared with that in normal livers by TCGA database (p \< 0.0001) ([Figure 1](#fig1){ref-type="fig"}D). Collectively, MAGEA3 and LINC01234 are highly expressed in HCC.Figure 1MAGEA3/LINC01234/miR-31-5p Axis Is Associated with the Development and Progression of HCC(A) The expression of MAGEA3 in HCC and normal livers in TCGA database. (B) The relationship between MAGEA3 expression and survival time of HCC patients based on data analysis in TCGA database. (C) The predicted miRNAs targeting MAGEA3 in four databases ([microRNA.org](http://microRNA.org){#intref0065}, [targetscan.org](http://targetscan.org){#intref0070}, miRTarBase, and mirDIP online database). (D) The expression of LINC01234 in HCC and normal livers in TCGA database.

Downregulation of MAGEA3 Inhibits the Proliferation and Invasion but Promotes Apoptosis of HCC Cells {#sec2.2}
----------------------------------------------------------------------------------------------------

We sought to explore how MAGEA3 influences HCC cells and small interfering RNAs (siRNAs) targeting MAGEA3 (si-MAGEA3-1 and si-MAGEA3-2) were transfected into HepG2 cells. As shown in [Figure 2](#fig2){ref-type="fig"}A, the expression of MAGEA3 in HepG2 cells was suppressed upon si-MAGEA3-1 or si-MAGEA3-2 transfection. Therefore, si-MAGEA3-2 (si-MAGEA3) with the highest silencing efficiency in HepG2 cells was selected for subsequent use. Consistently, si-MAGEA3-2 in Huh7 cells also exhibited the highest silencing efficiency ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Then the viability of HepG2 cells and Huh7 cells was assessed using 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. Significant decreases in viability of HepG2 cells and that of Huh7 cells were detected at 24, 48, or 72 h after si-MAGEA3 transfection ([Figure 2](#fig2){ref-type="fig"}B; [Figure S1](#mmc1){ref-type="supplementary-material"}B). Chemoresistance of HCC cells to cisplatin remains as a big challenge for the treatment of HCC.[@bib20] In order to investigate the effects of MAGEA3 on HCC cell chemoresistance to cisplatin, we explored whether knocking down MAGEA3 could influence cisplatin-induced apoptosis of HepG2 cells and Huh7 cells using flow cytometry. As depicted in [Figure 2](#fig2){ref-type="fig"}C and [Figure S1](#mmc1){ref-type="supplementary-material"}C, knocking down MAGEA3 potentiated apoptosis of HepG2 cells and Huh7 cells induced through low-concentration cisplatin (3 μg/mL) (p \< 0.05). Additionally, we analyzed the effect of MAGEA3 on cell invasion. HepG2 cells and Huh7 cells were cultured in the Transwell chamber pre-coated with Matrigel. The results showed that the invasion of HepG2 cells and Huh7 cells was obviously attenuated upon the silence of MAGEA3 ([Figure 2](#fig2){ref-type="fig"}D; [Figure S1](#mmc1){ref-type="supplementary-material"}D). Moreover, the protein expression of E-cadherin in HepG2 cells and Huh7 cells was measured by applying western blot analysis, which displayed that the protein expression of E-cadherin, was reduced in response to MAGEA3 depletion ([Figure 2](#fig2){ref-type="fig"}E; [Figure S1](#mmc1){ref-type="supplementary-material"}E). Collectively, MAGEA3 might be oncogenic, and the knockdown of MAGEA3 could reduce proliferation and invasion while enhancing apoptosis of HepG2 cells and Huh7 cells.Figure 2MAGEA3 Knockdown Contributes to Suppressed Proliferation and Invasion but Promoted Apoptosis of HepG2 Cells(A) The mRNA level of MAGEA3 in HepG2 cells transfected with designated siRNAs determined by qRT-PCR. (B--D) The viability (B), apoptosis (C), and invasion (×200; D) of HepG2 cells upon transfection with si-MAGEA3 assessed by MTT, flow cytometry, and Transwell assays, respectively. (E) Protein expression of E-cadherin in HepG2 cells measured using western blot analysis. Measurement data were expressed as mean ± SD. Differences among groups at different points of time were assessed with repeated-measures ANOVA. The comparisons among multiple groups were assessed with one-way ANOVA, followed by Tukey's post hoc test. Each experiment was repeated three times. \*p \< 0.05 versus the mock- or si-NC-transfected cells.

MAGEA3 Depletion Attenuates Chemoresistance of HCC Cells to Cisplatin {#sec2.3}
---------------------------------------------------------------------

To assess the effects of MAGEA3 silencing on chemoresistance of HCC cells to cisplatin, HepG2 cells and Huh7 cells were transfected with siRNAs and treated with various concentrations of cisplatin (0, 2.5, 5, 10, 20, and 40 μg/mL) for 48 consecutive h. A cell counting kit-8 (CCK-8) assay revealed that the 50% inhibitive concentration (IC~50~) of mock HepG2 cells and siRNA-negative control (si-NC)-transfected HepG2 cells was 13.6 μg/mL, which was relatively higher in comparison to the HepG2 cells transfected with si-MAGEA3 (5.3 μg/mL). This indicated that the IC~50~ of HepG2 cells was reduced in response to MAGEA3 depletion (p \< 0.05) ([Figure 3](#fig3){ref-type="fig"}A). Multidrug resistance-associated protein 2 (MRP2), MRP3, and multidrug resistance protein 1 (MDR-1), the hepatobiliary transporters, induce chemoresistance of HCC cells and significantly limit the therapeutic efficiency of chemotherapy in HCC patients.[@bib5]^,^[@bib21] Moreover, as displayed in [Figures 3](#fig3){ref-type="fig"}B and 3C, the expression of MRP2, MRP3, and MDR-1 was reduced upon silence of MAGEA3. ELISA detection of albumin (ALB) in the supernatant of HepG2 cells showed that knocking down MAGEA3 elevated ALB content ([Figure 3](#fig3){ref-type="fig"}D). Further, consistent regulatory effects of si-MAGEA3 on HepG2 cells were detected in Huh7 cells ([Figure S2](#mmc1){ref-type="supplementary-material"}). Thus, MAGEA3 knockdown might efficiently decrease the resistance of HepG2 cells and Huh7 cells to cisplatin.Figure 3The Knockdown of MAGEA3 Reduces the Resistance of HepG2 Cells to Cisplatin(A) CCK-8 assay showing viability and the IC~50~ of HepG2 cells transfected with mock, si-NC, or si-MAGEA3 upon treatment with cisplatin at different concentrations. (B) The mRNA levels of MRP2, MRP3, and MDR-1 in HepG2 cells transfected with si-MAGEA3 upon cisplatin treatment determined by qRT-PCR. (C) The protein levels of MRP2, MRP3, and MDR-1 in HepG2 cells transfected with si-MAGEA3 upon cisplatin treatment measured using western blot analysis. (D) ALB content in the supernatant of HepG2 cells in response to si-MAGEA3 transfection detected by ELISA. Measurement data were expressed as mean ± SD. The comparisons among multiple groups were assessed with one-way ANOVA, followed by Tukey's post hoc test. Each experiment was repeated three times. \*p \< 0.05 versus the mock- or si-NC-transfected cells.

miR-31-5p Targets MAGEA3 and Represses HCC Development *In Vitro* as well as Chemoresistance of HCC Cells to Cisplatin {#sec2.4}
----------------------------------------------------------------------------------------------------------------------

As mentioned above, miR-31-5p and miR-448 were predicated to target MAGEA3, and further analysis in the TargetScan database revealed that miR-31-5p/miR-448 might target the 3′ UTR of MAGEA3 ([Figure 4](#fig4){ref-type="fig"}A). As shown in [Figure 4](#fig4){ref-type="fig"}B, upon overexpression of miR-31-5p or miR-448, luciferase activity was significantly reduced in HepG2 cells transfected with pmirGLO vector containing the 3′ UTR of MAGEA3. Additionally, luciferase activity of HepG2 cells transfected with pmirGLO vector containing the mutated 3′ UTR of MAGEA3 was not influenced by miR-31-5p or miR-448 expression ([Figure 4](#fig4){ref-type="fig"}B), demonstrating the specificity of the binding of miR-31-5p and miR-448 to the 3′ UTR of MAGEA3. Therefore, both miR-31-5p and miR-448 could directly target MAGEA3.Figure 4Upregulation miR-31-5p Hinders HCC Progression and Chemoresistance of HepG2 Cells to Cisplatin by Depleting MAGEA3(A) The binding sites of miR-31-5p and miR-448 in the 3′ UTR region of MAGEA3 predicted by TargetScan. (B) The luciferase activity of MAGEA3-WT and MAGEA3-Mut in HepG2 cells after miR-31-5p or miR-448 mimic transfection. (C--E) The viability (C), invasion (×200; D), and cisplatin-induced apoptosis (E) of HepG2 cells following miR-31-5p mimic transfection evaluated by MTT assay, Transwell assay, and flow cytometry, respectively. (F) IC~50~ value of HepG2 cells following miR-31-5p mimic transfection. (G) Western blot analysis showing protein expression of MRP2, MRP3, MDR-1, and E-cadherin in HepG2 cells after restoration of miR-31-5p. (H) Content of ALB in supernatant of HepG2 cells following overexpression of miR-31-5p detected by ELISA. Measurement data were expressed as mean ± SD. The comparison between the two groups was analyzed by independent sample t test and the comparisons among multiple groups by one-way ANOVA, followed by Tukey's post hoc test. Each experiment was repeated three times. \*p \< 0.05 versus the NC-transfected cells.

Considering that miR-31-5p triggered more significant post-transcriptional downregulation of MAGEA3, miR-31-5p was applied for subsequent use in the present study. Initially, MTT assay was adopted to measure the influence of miR-31-5p on the viability of HepG2 cells and Huh7 cells, and the decreased growth rates upon miR-31-5p mimic transfection were observed ([Figure 4](#fig4){ref-type="fig"}C; [Figure S3](#mmc1){ref-type="supplementary-material"}A). Additionally, enforced miR-31-5p expression contributed to suppressed invasion of HepG2 cells and Huh7 cells ([Figure 4](#fig4){ref-type="fig"}D; [Figure S3](#mmc1){ref-type="supplementary-material"}B), downregulated protein expression of E-cadherin in HepG2 cells and Huh7 cells ([Figure 4](#fig4){ref-type="fig"}G; [Figure S3](#mmc1){ref-type="supplementary-material"}E), and enhanced apoptosis of HepG2 cells and Huh7 cells ([Figure 4](#fig4){ref-type="fig"}E; [Figure S3](#mmc1){ref-type="supplementary-material"}C). Furthermore, the effect of miR-31-5p on HCC cell chemoresistance to cisplatin was assessed, and it was found that miR-31-5p mimic transfection resulted in reduced IC~50~ in HepG2 cells and Huh7 cells ([Figure 4](#fig4){ref-type="fig"}F; [Figure S3](#mmc1){ref-type="supplementary-material"}D), together with downregulated expression of MRP2, MRP3, MDR-1 ([Figure 4](#fig4){ref-type="fig"}G; [Figure S3](#mmc1){ref-type="supplementary-material"}E), and elevated content of ALB ([Figure 4](#fig4){ref-type="fig"}H; [Figure S3](#mmc1){ref-type="supplementary-material"}F). Collectively, miR-31-5p suppressed the progression of HCC *in vitro* and reduced HCC cell chemoresistance to cisplatin.

LINC01234 Silencing Represses MAGEA3-Dependent HCC Progression by Negatively Mediating miR-31-5p {#sec2.5}
------------------------------------------------------------------------------------------------

RNA-fluorescence *in situ* hybridization (FISH) exhibited that LINC01234 was mainly located in the cytoplasm of HepG2 cells and Huh7 cells ([Figure 5](#fig5){ref-type="fig"}A; [Figure S4](#mmc1){ref-type="supplementary-material"}A), suggesting that LINC01234 might exert regulatory function in the cytoplasm. As bioinformatics analysis showed that LINC01234 could bind to miR-31-5p, a dual-luciferase reporter gene assay was employed to analyze this relationship. As shown in [Figure 5](#fig5){ref-type="fig"}B and [Figure S4](#mmc1){ref-type="supplementary-material"}B, luciferase activity of the pmirGLO vector containing the LINC01234 sequence was notably decreased upon miR-31-5p expression in HepG2 cells and Huh7 cells. However, luciferase activity of the pmirGLO vector containing the mutated LINC01234 sequence was hardly affected by miR-31-5p mimic transfection ([Figure 5](#fig5){ref-type="fig"}B; [Figure S4](#mmc1){ref-type="supplementary-material"}B).Figure 5Depleted LINC01234 Enhances miR-31-5p-Mediated Downregulation of MAGEA3 to Prevent HCC Progression(A) The subcellular localization of LINC01234 in HepG2 cells identified by FISH (×400). (B) The luciferase activity of LINC01234 in HepG2 cells upon miR-31-5p mimic transfection in a dual-luciferase reporter system. (C) The binding between LINC01234 and miR-31-5p detected by RNA pull-down. (D) The binding between LINC01234 and Ago2 or DICER detected by RIP. (E) MAGEA3 expression in HepG2 cells in response to altered expression of LINC01234 and/or miR-31-5p measured using qRT-PCR. (F) Binding of miR-31-5p to MAGEA3 in HepG2 cells detected using RNA pull-down. (G--I) The viability (G), invasion (×200; H), and cisplatin-induced apoptosis (I) of HepG2 cells upon inhibition of LINC01234 and/or miR-31-5p assessed using MTT, Transwell, and flow cytometry assays. (J) IC~50~ value of HepG2 cells upon inhibition of LINC01234 and/or miR-31-5p. (K) Protein expression of MRP2, MRP3, MDR-1, and E-cadherin in HepG2 cells upon inhibition of LINC01234 and/or miR-31-5p determined using western blot analysis. (L) ALB content in the supernatant of HepG2 cells upon inhibition of LINC01234 and/or miR-31-5p detected by ELISA. Measurement data were expressed as mean ± SD. Differences among groups at different points of time were assessed with repeated-measures ANOVA. The comparison between two groups was analyzed by independent sample t test and the comparisons among multiple groups by one-way ANOVA, followed by Tukey's post hoc test. Each experiment was repeated three times. \*p \< 0.05 versus the IgG immunoprecipitates or the NC- or si-ctrl-transfected cells; \#p \< 0.05 versus the si-LINC01234-transfected cells.

Furthermore, the data from the RNA pull-down assay exhibited that LINC01234 was abundantly enriched in the wild-type miR-31-5p group in comparison with the negative control (NC) or mutated miR-31-5p group (p \< 0.05) ([Figure 5](#fig5){ref-type="fig"}C; [Figure S4](#mmc1){ref-type="supplementary-material"}C). These data revealed the specific binding between LINC01234 and miR-31-5p. Meanwhile, RNA-binding protein immunoprecipitation (RIP) experiments were performed, and both HepG2 and Huh7 cell lysate were incubated with antibody to Argonaute 2 (Ago2) or DICER, the effector component of the RISC complex. As shown in [Figure 5](#fig5){ref-type="fig"}D and [Figure S4](#mmc1){ref-type="supplementary-material"}D, enrichment of LINC01234 in Ago2- or DICER-immunoprecipitated complex was increased in comparison with the control immunoglobulin G (IgG)-immunoprecipitated complex (p \< 0.05), indicating that LINC01234 could bind to Ago2 or DICER.

Expression of LINC01234 in HepG2 cells and Huh7 cells was silenced in order to explore the functions of LINC01234. As determined by qRT-PCR, knocking down LINC01234 reduced MAGEA3 expression in HepG2 cells and Huh7 cells; however, increase of MAGEA3 caused by si-LINC01234 was inhibited by miR-31-5p inhibitor ([Figure 5](#fig5){ref-type="fig"}E; [Figure S4](#mmc1){ref-type="supplementary-material"}E). Besides, data of the RNA pull-down assay demonstrated that silencing of LINC01234 could enhance the binding of miR-31-5p to MAGEA3 ([Figure 5](#fig5){ref-type="fig"}F; [Figure S4](#mmc1){ref-type="supplementary-material"}F). Moreover, depletion of LINC01234 suppressed viability ([Figure 5](#fig5){ref-type="fig"}G; [Figure S4](#mmc1){ref-type="supplementary-material"}G) and invasion ([Figure 5](#fig5){ref-type="fig"}H; [Figure S4](#mmc1){ref-type="supplementary-material"}H) and downregulated the protein expression of E-cadherin ([Figure 5](#fig5){ref-type="fig"}K; [Figure S4](#mmc1){ref-type="supplementary-material"}K), but it promoted cisplatin-induced apoptosis ([Figure 5](#fig5){ref-type="fig"}I; [Figure S4](#mmc1){ref-type="supplementary-material"}I) of HepG2 cells and Huh7 cells. Additionally, it was found that when compared with si-NC transfection, si-LINC01234 transfection led to a reduced IC~50~ value in HepG2 cells and Huh7 cells ([Figure 5](#fig5){ref-type="fig"}J; [Figure S4](#mmc1){ref-type="supplementary-material"}J), downregulated protein expression of MRP2, MRP3, and MDR-1 ([Figure 5](#fig5){ref-type="fig"}K; [Figure S4](#mmc1){ref-type="supplementary-material"}K), but upregulated expression of ALB ([Figure 5](#fig5){ref-type="fig"}L; [Figure S4](#mmc1){ref-type="supplementary-material"}L). However, the anti-proliferative, pro-apoptotic, and chemosensitizing effects of LINC01234 silencing were reversed through miR-31-5p depletion. Collectively, reduction of LINC01234 upregulated miR-31-5p to downregulate MAGEA3 expression, thereby further suppressing malignant phenotype of HCC cells.

Discussion {#sec3}
==========

Currently, HCC prognosis in patients at late stage remains poor.[@bib22] In the current study, LINC01234 and MAGEA3 were found to be upregulated in HCC in accordance to TCGA data and could bind to miR-31-5p. Since the interactions among the three factors remain to be clarified, our study was conducted to elucidate the mechanism of how they function in the progression and chemoresistance of HCC.

The dysregulated expression of lncRNAs is associated with HCC tumors.[@bib23] HCC-related lncRNAs can mediate cell proliferation, apoptosis, invasion, metastasis, as well as angiogenesis, thereby participating in diverse processes during HCC progression.[@bib24] Several lncRNAs are evident to have a high expression in HCC, such as uc003wbd, AF085935, and BANCR.[@bib25]^,^[@bib26] LINC01234 is upregulated in stomach adenocarcinoma,[@bib27] but its role remains unknown in HCC. The findings from the study displayed that siRNA-mediated silencing of LINC01234 could suppress proliferation and invasion of both HepG2 and Huh7 cells while elevating cisplatin-induced cell apoptosis. Hence, our data suggest that downregulation of LINC01234 could exert an inhibitory effect on HCC progression and a chemosensitizing effect. This might provide insightful therapeutic targets for HCC. Recently, multiple studies have revealed that lncRNAs could interact with miRNAs to function in diseases and human cancers.[@bib28]^,^[@bib29] Our results revealed that LINC01234 regulated miR-31-5p to mediate HCC progression. Silencing of LINC01234 upregulated miR-31-5p to restrain malignant phenotypes of HCC cells and to enhance cisplatin-induced apoptosis.

miR-31-5p has been revealed to be poorly expressed in prostate cancer.[@bib30] A recent study has identified a close relationship between miR-31-5p and liver function.[@bib31] Also, a large number of miRNAs negatively target genes by binding to 3′ UTR regions.[@bib32] Furthermore, it was confirmed that MAGEA3 was a target of miR-31-5p, which is in line with previous studies conducted.[@bib33]^,^[@bib34] Additionally, the current study further demonstrates that MAGEA3 silencing reduced HepG2 and Huh7 cell proliferation and invasion, while also increasing cell apoptosis *in vitro*. In this study, RNA pull-down and RIP assays identified the binding between LINC01234 and MAGEA3 to miR-31-5p. It is speculated that LINC01234 reduction could upregulate miR-31-5p to inhibit MAGEA3, leading to suppression in malignant phenotype of HCC cells.

MRPs are ATP-binding cassette transporters, endowing tumor cells with multidrug resistance via reducing the uptake of anticancer drugs.[@bib35] Downregulation of MDR-1 and MRP could lead to intracellular accumulation of anticancer drugs to enhance the efficiency of chemotherapy.[@bib36] Besides, MDR-1 gene polymorphism (c.4125A \> C) is associated with HCC susceptibility in the Chinese population and may be a risk factor.[@bib37]^,^[@bib38] Thus, the MDR-1 gene may be a potential target for HCC treatment. It was also found that MAGEA3 depletion diminished the resistance of HepG2 cells to cisplatin by reducing MRP2, MRP3, and MDR-1. The results obtained from the study are consistent with a previous report that miRNA double-strand fragments mediated knockdown of MAGEA3 leads to the reduced cell proliferation and enhanced docetaxel sensitivity in gastric cancer-derived cells.[@bib39] Recently, the correlation between lncRNAs and chemoresistance in HCC has also been identified.[@bib40]^,^[@bib41] According to aforementioned results, silencing of LINC01234 could overcome HCC cell chemoresistance through MAGEA3 depletion.

In conclusion, LINC01234 downregulation could suppress the progression and chemoresistance in HCC by reducing miR-31-5p-mediated inhibition of MAGEA3 ([Figure 6](#fig6){ref-type="fig"}). Importantly, MAGEA3 could confer cisplatin resistance to HCC cells, and the LINC01234/miR-31-5p regulatory network might participate in the process. However, whether the LINC01234/miR-31-5p/MAGEA3 axis is involved in the modulation of HCC chemoresistance to other anticancer drugs needs to be further investigated. Besides, *in vivo* experiments should be conducted to further elucidate the mechanisms and verify whether the pathway plays a critical role in animals.Figure 6The LINC01234/miR-31-5p/MAGEA3 Axis Is Involved in Modulation of HCC Progression and Cisplatin ResistanceDownregulated LINC01234 increases miR-31-5p expression, thus reducing MAGEA3 expression in HCC cells. Subsequently, the proliferation and invasion of HCC cells were attenuated, while the apoptosis was enhanced. In addition, the reduced expression of MRP2, MRP3, and MDR-1 were detected during these processes.

Materials and Methods {#sec4}
=====================

Bioinformatics Prediction {#sec4.1}
-------------------------

To identify HCC-related genes, microarray data of HCC were acquired from TCGA database (<http://cancergenome.nih.gov/about-nci/organization/ccg/research/structural-genomics/tcga>), followed by differential analysis with the edgeR package.[@bib42] The FDR of genes was obtained by p value correction using package multitest. Then, DEGs were screened out with the threshold of FDR \<0.05 and \|log2 (fold change)\| \> 2.

Cell Culture {#sec4.2}
------------

HepG2 cells (American Type Culture Collection, Manassas, VA, USA) and Huh7 cells (Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China) (<http://www.cellbank.org.cn/index.asp>) were cultured in DMEM containing 10% fetal bovine serum (FBS) in a 5% CO~2~ incubator at 37°C. The adhered cells were passaged and detached by applying 0.25% trypsin (Hyclone, Logan, UT, USA). Cells in logarithmic growth period were used for further experiments.

Transient Transfection {#sec4.3}
----------------------

Both HepG2 and Huh7 cells were seeded into 50-mL culture bottles and grown in complete medium to reach 50%--60% confluence. A total of 5 μL Lipofectamine 2000 transfection reagents, 100 μL serum-free medium, and 50 nmol RNA was mixed in accordance to the guidelines provided by the Lipofectamine 2000 transfection kit (11668019, Invitrogen, Carlsbad, CA, USA) and added into the cells after incubation. After 6--8 h of transfection, the medium was replaced with fresh complete medium. Transfected RNAs, including mimic, inhibitor, siRNA were all synthesized by GenePharma (Shanghai, China).

RNA Extraction and Quantification {#sec4.4}
---------------------------------

Total RNA extracted from HepG2 cells and Huh7 cells was reversely transcribed into cDNA with a reverse transcription kit (Beijing TransGen Biotech, Beijing, China). qPCR was performed by applying the SYBR Premix Ex Taq II kit (TaKaRa Biotechnology (Dalian), Liaoning, China) on an ABI7500 instrument (Applied Biosystems, Carlsbad, CA, USA). The primers ([Table 1](#tbl1){ref-type="table"}) were synthesized by Shanghai Sangon Biotechnology (Shanghai, China). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and U6 were used as internal references, and the fold changes were calculated by means of relative quantification (2^−ΔΔCt^ method).[@bib43]Table 1Primer Sequences for qRT-PCRGeneSequenceLINC01234F, 5′-TCACCTCCTCGGTCTCAGTT-3′R, 5′-GGGTGAGAAGAGACAAGCGT-3′miR-31-5pF, 5′-GTCGTATCCAGTGCAGGGTCCGA\
GGTATTCGCACTGGATACGACAGCTAT-3′R, 5′-TAATACTGCCTGGTAATGATGA-3′MAGEA3F, 5′-GAAGCCGCCCCAGGCTCG-3′R, 5′-GGAGTCCTCATAGGATTGGCTCC-3′MRP2F, 5′-CCTCACAAACTGCCTCTTCA-3′R, 5′-AGCCCAATGGAAGCAATATC-3′MRP3F, 5′-ACAACCTCATCCAGGCTACC-3′R, 5′-GGTTGGCTGGAGAATCAAAT-3′MDR-1F, 5′-ATGCCTTCATCGAGTCACTG-3′R, 5′-TAACAAGGGCACGAGCTATG-3′U6F, 5′-GTCGTATCCAGTGCAGGGTCCGAGG\
TGCACTGGATACGACAAAATATGGAAC-3′R, 5′-GTGCTCGCTTCGGCAGC-3′GAPDHF, 5′-CGGAGTCAACGGATTTGGTCGTAT-3′R, 5′-AGCCTTCTCCATGGTGGTGAAGAC-3′[^2]

MTT Assay for Cell Viability {#sec4.5}
----------------------------

At the time points of 0, 24, 48, and 72 h post-transfection, both HepG2 and Huh7 cells were incubated with MTT. After incubation, dimethyl sulfoxide was added to dissolve the produced formazan. The optical density value was measured at 570 nm using an enzyme immunoassay analyzer (ZY057877, Beijing Zhongyi Kexin Technology, Beijing, China). Mean values were calculated from cell samples in three replicate wells.

Transwell Assay for Cell Invasion {#sec4.6}
---------------------------------

Transwell assay was conducted 24 h post-transfection. After being detached and suspended in serum-free DMEM medium, HepG2 cells and Huh7 cells were starved in serum-free culture medium for 24 consecutive h. After detachment, the cells were dispersed to cell suspension at a density of 3 × 10^5^ cells/mL. Then, 100 μL HepG2 cell suspension or 100 μL Huh7 cell suspension was added into the apical chamber pre-coated with Matrigel (1:10, Becton Dickinson, Franklin Lakes, NJ, USA), while 600 μL DMEM medium containing 10% serum (as the chemokine) was added to the basolateral chamber. In accordance with the manufacturer's protocols of Transwell system (Corning, Corning, NY, USA), the total number of transmembrane cells was tallied via crystal violet staining.

Flow Cytometry for Cell Apoptosis {#sec4.7}
---------------------------------

An Annexin V-fluorescein isothiocyanate/propidium iodide (Annexin V-FITC/PI) detection kit (556547, Shanghai Shuojia Biotechnology, Shanghai, China) was utilized to measure apoptosis of HepG2 cells and Huh7 cells. After 48 h of transfection, HepG2 cells and Huh7 cells were further treated with cisplatin (3 μg/mL) for 48 h. In brief, cells were centrifuged at 2,000 rpm for 5 min, suspended in pre-cold 1× PBS, and then centrifuged again at 200 rpm for 5--10 min. Next, cells were resuspended in 300 μL 1× binding buffer, and 5 μL Annexin V-FITC was added, followed by 15 min of incubation in avoidance of light. Then, 5 μL PI solution was added and incubated in ice bath under dark conditions for 5 min. Fluorescence intensities were determined using the Partec Cube 6 flow cytometer (Partec, Munster, Germany) using the excitation wavelength at 480 nm and a 530-nm band-pass filter for FITC detection and a 575-nm long-pass filter for PI detection. Annexin V-FITC-stained cells presented green fluorescence, and non-vital PI-stained cells were displayed in a red fluorescence. Based on the staining fluorescence, intact cells (FITC^−^PI^−^), apoptotic cells at early stage (FITC^+^PI^−^), and apoptotic cells at late stage or necrotic cells (FITC^+^PI^+^) were discriminated.

CCK-8 Assay for Drug Resistance {#sec4.8}
-------------------------------

After 48 consecutive h of transfection, HepG2 cells and Huh7 cells were collected and seeded into a 96-well plate (1 × 10^4^ cells/well). The adhered cells were then cultured in a series of medium with an increasing dose of cisplatin (0, 2.5, 5, 10, 20, and 40 μg/mL) for 48 h. Next, the cells were incubated with 10% CCK-8 solution (JK-021, Shanghai Jingke Chemical Technology, Shanghai, China) in the dark for 2 h. The absorbance at 450 nm was detected using a microplate reader, and the IC~50~ of cisplatin was calculated.

Western Blot Analysis {#sec4.9}
---------------------

Total proteins were extracted from HepG2 cells and Huh7 cells using radio-immunoprecipitation assay lysis buffer (Beyotime Biotechnology, Shanghai, China). After protein quantitation using the bicinchoninic acid assay, the proteins were separated by PAGE with a 5% stacking gel and a 10% separating gel and then transferred onto a nitrocellulose membrane using wet transfer apparatus. Next, the membrane was blocked with 5% BSA for 1 h and incubated with the diluted rabbit anti-human antibodies from Abcam (Cambridge, UK) at 4°C overnight: MDR-1 (ab129450, 1:1,000), MRP2 (ab203397, 1:500), MRP3 (ab107083, 1:250), GAPDH (ab37168, 1 μg/mL), and E-cadherin (ab15148, 1:500). Next, the membrane was washed using PBS/Tween-20 and further incubated by applying 5% skimmed milk-diluted secondary antibody goat anti-rabbit IgG (ab205718, 1: 5000) for 1 h in avoidance of light. Subsequently, the protein bands were developed and visualized in a gel imaging system (MG8600, Bio-Rad, Hercules, CA, USA). Images were analyzed using the Image-Pro Plus software (Version 7.0, Media Cybernetics, Silver Springs, MD, USA). The expression levels of target proteins relative to GAPDH were calculated.

ELISA {#sec4.10}
-----

According to the protocols of the ELISA kits (R&D Systems, Minneapolis, MN, USA), the content of ALB in cell supernatant was measured.

RNA-FISH {#sec4.11}
--------

The subcellular localization of LINC01234 in HepG2 cells and Huh7 cells was detected in strict accordance to the guidelines provided by the FISH kit (C10910, RiboBio, Guangzhou, Guangdong, China). The cells were detached and cultured in the 24-well plate. Upon reaching 60%--70% confluence, cells were rinsed using 1× PBS, followed by 4% paraformaldehyde fixation. Next, cells were permeabilized for 5 min at 4°C and blocked in 200 μL pre-hybridization solution at 37°C for 30 min. Meanwhile, the hybridization solution was pre-heated and mixed with 2.5 μL 20 μM FISH probe mix. Cells were incubated with 1 mL probe-containing hybridization solution at 37°C overnight in avoidance of light. After the cells were washed, they were stained using DAPI for 10 min and sealed prior to fluorescence detection. The probes against LINC01234 were synthesized by RiboBio (Guangzhou, Guangdong, China).

Dual-Luciferase Reporter Assay {#sec4.12}
------------------------------

The sequence of LINC01234 and the 3′ UTR of MAGEA3 were cloned into the pmirGLO vectors (E1330, Promega, Madison, WI, USA) to generate LINC01234-wild-type (WT) and MAGEA3-WT plasmids. Next, site-specific mutagenesis was performed to create LINC01234 mutant (Mut) and MAGEA3-Mut plasmids. The pRL-TK renilla luciferase reporter vector (E2241, Promega, Madison, WI, USA) was used as the internal reference. Both NC and miR-31-5p mimic were co-transfected with the constructed luciferase reporter vectors into HepG2 cells or Huh7 cells. The relative luciferase activity was calculated as the ratio of the signal of firefly luciferase to that of renilla luciferase. The luciferase signals were measured in strict accordance to the guidelines provided by the dual-luciferase reporter gene assay kit (GM-040502A, Qcbio Science and Technologies, Shanghai, China) at 560 nm for the firefly luciferase and 465 nm for the renilla luciferase.

RNA Pull-Down {#sec4.13}
-------------

In brief, HepG2 cells and Huh7 cells were treated using 50 nM biotinylated WT miR-31-5p (WT-bio-miR-31-5p) or Mut miR-31-5p (Mut-bio-miR-31-5p). After 48 consecutive h, the cells were collected and lysed with specific lysis buffer (Ambion, Austin, TX, USA) for 10 min. The lysate was then incubated with M-280 streptavidin magnetic beads (S3762, Sigma-Aldrich, St. Louis, MO, USA) pre-coated using RNase-free BSA and yeast tRNA (TRNABAK-RO, Sigma-Aldrich, St. Louis, MO, USA) at 4°C for 3 h. The beads were then washed using the following buffer: pre-cold lysis buffer (two times), low-salt buffer (three times), and high-salt buffer. After the bound RNA was purified using the Trizol reagent, qRT-PCR was performed to analyze LINC01234 content.

RIP {#sec4.14}
---

HepG2 cells and Huh7 cells were lysed using the lysis buffer (25 mM Tris-HCl \[pH 7.4\], 150 mM NaCl, 0.5% Nonidet P-40, 2 mM ethylene diamine tetraacetic acid, 1 mM NaF, and 0.5 mM dithiothreitol) containing RNasin (Takara Bio, Otsu, Shiga, Japan) and protease inhibitor (B14001a, Roche, Madison, WI, USA). The lysate was then centrifuged for 30 min, and the supernatant was subjected to immunoprecipitation with anti-Ago2 or anti-DICER antibody-coated magnetic beads (BMFA-1, Biomarker Technologies, Beijing, China) or anti-IgG-coated magnetic beads as the control. After incubation at 4°C for 4 h, the beads were washed three times using the wash buffer (50 mM Tris-HCl, 300 mM NaCl \[pH 7.4\], 1 mM MgCl~2~, 0.1% Nonidet P-40). Finally, RNA was extracted with Trizol reagent from the beads, followed by qRT-PCR detection.

Statistical Analysis {#sec4.15}
--------------------

All experimental data were processed and analyzed using SPSS 22.0 statistical software (IBM, Armonk, NY, USA). The data are presented as mean ± SD. The differences between two groups were compared using an independent sample t test. Comparisons among multiple groups were analyzed using one-way ANOVA, followed by Tukey's post hoc test. Statistical significance was considered at p \< 0.05.
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